Investing.com -- Avolta on Wednesday reported a strong financial performance for 2024, with revenues increasing by 8.9% at constant exchange rates and organic growth reaching 6.3%.

Partners Group / Key word (s): Statement Partners Group shares key messages from its Capital Markets Day 12-March-2025 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The ...

Ad hoc announcement pursuant to Art. 53 LRBaar, Switzerland, 12 March 2025Summary offinancial results for 2024: Net revenue of CHF 286.7 ...

EUR/USD keeps losses near 1.0900 in the European morning on Wednesday, snapping the three-day winning streak. EU responds with countermeasures to US tariffs on steel, exerting downward pressure on the ...

Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Tecan reports 2024 financial results, enhancing operational resilience amid challenging conditions Financial ...

Alkem Laboratories announced the launch of generic empagliflozin and its combinations in India under the brand name Empanorm at prices that are approximately 80% lower than the innovator products.

Mercy Keeps Patients With Heart Failure Healthier and Out of the Hospital. Mercy’s new specialized programs are in communities with some of the highest rates of heart failure in ...

Successful 2024 marked by significant clinical advancements across Oculis' late-stage and highly differentiated clinical ...

Discover why high blood pressure earned its "silent killer" nickname, how it damages organs without symptoms, and the ...